C. Barbara
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 17
- Colorectal Cancer Treatments and Studies 12
- Cancer Cells and Metastasis 1
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Alfredo Falcone (11 shared papers)Giacomo Allegrini (11 shared papers)Gianluca Masi (9 shared papers)Cristina Granetto (6 shared papers)Silvana Chiara (4 shared papers)Lucio Crinò (2 shared papers)Isa Maura Brunetti (3 shared papers)Stefano Vitello (3 shared papers)
- Journals
- Annals of Oncology (7 papers)Therapeutic Drug Monitoring (2 papers)Clinical Colorectal Cancer (1 paper)European Journal of Pharmacology (1 paper)Journal of Chemotherapy (1 paper)
- Partner nations
- Italy
In The Last Decade
C. Barbara
29 papers receiving 1.9k citations
C. Barbara's Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 1.4k
- Pharmacology 124
- Cancer Research 151
- Hepatology 52
- Analytical Chemistry 36
Countries citing papers authored by C. Barbara
This map shows the geographic impact of C. Barbara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Barbara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Barbara more than expected).
Fields of papers citing papers by C. Barbara
This network shows the impact of papers produced by C. Barbara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Barbara. The network helps show where C. Barbara may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Barbara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest Hit paper breakdown → | 2007 | 981 |
| 2 | 2018 | 348 | |
| 3 | 2015 | 147 | |
| 4 | 1999 | 66 | |
| 5 | 2006 | 63 | |
| 6 | 2002 | 47 | |
| 7 | 2013 | 47 | |
| 8 | 2016 | 45 | |
| 9 | 2019 | 44 | |
| 10 | 2011 | 39 | |
| 11 | 2017 | 35 | |
| 12 | 2004 | 23 | |
| 13 | 2006 | 23 | |
| 14 | 2006 | 17 | |
| 15 | 2000 | 15 | |
| 16 | 2005 | 14 | |
| 17 | 2011 | 9 | |
| 18 | 2019 | 9 | |
| 19 | 2008 | 8 | |
| 20 | 2013 | 6 |
About C. Barbara
C. Barbara is a scholar working on Oncology, Pharmacology, Dermatology, Toxicology and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Pharmacogenetics and Drug Metabolism (4 papers), Cancer therapeutics and mechanisms (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Bioactive Compounds and Antitumor Agents (1 paper), Lung Cancer Treatments and Mutations (1 paper), Renal cell carcinoma treatment (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Oncology (1.4k citations), Pharmacology (124 citations), Cancer Research (151 citations), Hepatology (52 citations) and Analytical Chemistry (36 citations). C. Barbara has collaborated with scholars based in Italy. Frequent co-authors include Alfredo Falcone, Giacomo Allegrini, Gianluca Masi, Cristina Granetto, Silvana Chiara, Lucio Crinò, Isa Maura Brunetti, Stefano Vitello, Michele Andreuccetti and Laura Fanchini. Their work appears in journals such as Annals of Oncology, Therapeutic Drug Monitoring, Clinical Colorectal Cancer, European Journal of Pharmacology and Journal of Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.